← Open Payments lookup

LISA COLASURDO: Open Payments

NPI 1447246616 · INMAN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$563 in 22 payments from 11 companies in 2025. Trend: 2023 $980 · 2024 $930 · 2025 $563

Food & beverage: $563
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$150
Amgen Inc.4$135
Abbott Laboratories3$63
ABIOMED3$51
Novartis Pharmaceuticals Corporation2$44
Novo Nordisk Inc2$32
Dexcom, Inc.1$24
Eisai Inc.1$19
Merck Sharp & Dohme LLC1$16
Boehringer Ingelheim Pharmaceuticals, Inc.1$15

Products named: FARXIGA, EVENITY, FREESTYLE LIBRE 3, LEQVIO, Wegovy, Dexcom G6 Transmitter, Leqembi, VAXELIS.

Industry payments across SC — which companies pay providers there.